| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 08/13/2009 | WO2009099086A1 3-substituted sulfonyl piperazine derivative |
| 08/13/2009 | WO2009099080A1 Novel phenylpyrrole derivative |
| 08/13/2009 | WO2009073508A3 Polysaccharide gel compositions and methods for sustained delivery of drugs |
| 08/13/2009 | WO2009073460A3 Inhibition of 11 beta-hydroxysteroid dehydrogenase type 1 for ocular neuroprotection |
| 08/13/2009 | US20090203751 Novel 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/13/2009 | US20090203614 Use of agents that prevent the generation of amyloid-like proteins and/or drusen, and/or use of agents that promote sequestration and/or degradation of, and/or prevent the neurotoxic effects of such proteins in the treatment of macular degeneration |
| 08/13/2009 | US20090203584 Peptide-based Compounds |
| 08/13/2009 | US20090202591 Leucine-based motif and clostridial neurotoxins |
| 08/13/2009 | US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 08/13/2009 | CA2715143A1 Novel phenylpyrrole derivative |
| 08/13/2009 | CA2714370A1 Compounds that enhance atoh-1 expression |
| 08/13/2009 | CA2714082A1 Peptides and peptide mimetics to treat pathologies associated with eye disease |
| 08/13/2009 | CA2713958A1 Substituted cyclopentanes having prostaglandin activity |
| 08/13/2009 | CA2711399A1 3-substituted sulfonylpiperidine derivative |
| 08/12/2009 | EP2088197A2 Haemophilus influenzae antigens and corresponding DNA fragments |
| 08/12/2009 | EP2087891A2 Pharmaceutical compositions for treating lymphoma |
| 08/12/2009 | EP2086530A1 Use of gabapentin and pregabalin prodrugs for treating tinnitus |
| 08/12/2009 | EP2086503A2 Sustained release drug delivery systems comprising a water soluble therapeutic agent and a release modifier |
| 08/12/2009 | EP2086502A1 Punctal plug comprising a water-insoluble polymeric matrix |
| 08/12/2009 | EP1567150B1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics |
| 08/12/2009 | EP1463735B1 Imidazo¬2,1-b -1,3,4-thiadiazole sulfonamides |
| 08/12/2009 | EP1385514B9 Spiroindene and spiroindane compounds |
| 08/12/2009 | EP1224170B1 6-position substituted indoline, production and use thereof as a medicament |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | CN101505794A scFV antibodies which pass epithelial and/or endothelial layers |
| 08/12/2009 | CN101505758A Pharmaceutical containing thiazole derivative as active ingredient |
| 08/12/2009 | CN101505749A Use of PKC inhibitors in particular indolylmaleimide derivatives in ocular diseases |
| 08/12/2009 | CN101505744A Antagonists of endothelial differentiation gene subfamily 3 (EDG-3, S1P3) receptors for prevention and treatment of ocular disorders |
| 08/12/2009 | CN101502648A 疫苗 Vaccine |
| 08/12/2009 | CN101502553A Rhizoma atractylodis total terpene alcohol solid dispersoid, medicament composition and preparation method thereof |
| 08/12/2009 | CN101502485A Nano cubic liquid crystal dexamethasone preparation for eye and preparation method thereof |
| 08/12/2009 | CN100526332C Application of endothelium inhibitant for preducing medicament for retina disease therapy |
| 08/12/2009 | CN100526307C Metalloproteinase inhibitors |
| 08/12/2009 | CN100525768C Novel compounds |
| 08/12/2009 | CN100525763C Mono- and bicyclic azole derivatives that inhibit the interaction of ligands with rage |
| 08/12/2009 | CN100525631C Non invasive measurements of chemical substances |
| 08/11/2009 | US7572886 Death associated proteins, and THAP1 and PAR4 pathways in apoptosis control |
| 08/11/2009 | US7572833 E.g., N-(4-fluorophenylsulfonyl)-L-valyl-L-leucinal stabilized with a lipid; improved absorption and penetration; treating ischemia, immune diseases, Alzheimer's disease, osteoporosis, brain disorders, eye diseases, osteoporosis |
| 08/11/2009 | US7572793 Tau protein kinase 1 inhibitors; treatment for neurodegenerative disorders; Alzheimer's Disease, Parkinson's disease, Pick's Disease, vision defects; antiischemic, antidiabetic, anticarcinogenic, antitumor agents, antidepressants |
| 08/11/2009 | US7572442 Selected antibody compositions for binding to aminophospholipids |
| 08/11/2009 | CA2537410C Ophthalmic indazole comprising compositions for treating ocular hypertension |
| 08/11/2009 | CA2359772C Cyclic substituted fused pyrrolocarbazoles and isoindolones |
| 08/06/2009 | WO2009097223A1 Substituted gamma lactams as therapeutic agents |
| 08/06/2009 | WO2009096526A1 Carboxylic acid compound or salt thereof |
| 08/06/2009 | WO2009096503A1 Benzyl phenyl glucopyranoside derivative |
| 08/06/2009 | WO2009096080A1 Piperidine derivative |
| 08/06/2009 | WO2009094713A1 Diagnosis and treatment of sensory defect |
| 08/06/2009 | WO2009036149A3 Methods for treatment of degenerative disease associated with apoptosis |
| 08/06/2009 | US20090197956 Treatment of acute otitis media with xylitol and n-acetylcysteine |
| 08/06/2009 | US20090197337 Methods for the production of multimeric proteins and related compositions |
| 08/06/2009 | US20090196903 Drug delivery devices, kits and methods therefor |
| 08/06/2009 | US20090196876 Novel Gene Disruptions, Compositions and Methods Relating Thereto |
| 08/06/2009 | CA2713293A1 Piperidine derivative |
| 08/06/2009 | CA2713043A1 Substituted gamma lactams as therapeutic agents |
| 08/05/2009 | EP2085389A1 Novel 1,2-dihydroquinoline derivative having (substituted phenyl or substituted heterocyclic) carbonyloxy lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085388A1 Novel 1,2-dihydroquinoline derivative having substituted phenylamino lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085387A1 Novel 1,2-dihydroquinoline derivative having substituted phenylchalcogeno lower alkyl group and ester-introduced phenyl group as substituents |
| 08/05/2009 | EP2085093A1 Preparation containing highly purified botulinum toxin type a derived from infant botulism pathogen |
| 08/05/2009 | EP2085086A2 Method for treating congestive heart failure or diabetic nephropathy |
| 08/05/2009 | EP2083876A2 Methods of wound care and treatment |
| 08/05/2009 | EP2083862A2 Compositions and methods for treating ocular diseases and conditions |
| 08/05/2009 | EP2083841A2 Treatment for age-related macular degeneration and other diseases of the eye |
| 08/05/2009 | EP2083808A1 Use of buprenorphine or n-alkylated derivatives thereof for wound healing |
| 08/05/2009 | EP1509506B1 Pyridazine derivatives |
| 08/05/2009 | EP1501797B1 3-(substituted amino)-1h-indole-2-carboxylic acid ester and 3-(substituted amino)-benzo[b]thiophene-2-carboxylic acid ester derivatives as interleukin-4 gene expression inhibitors |
| 08/05/2009 | EP1499735B1 Optimization of transgene expression in mammalian cells |
| 08/05/2009 | EP1465880B1 5-sulphanyl-4h-1,2,4-triazole derivatives and their use to treat disorders associated with somatostatine |
| 08/05/2009 | CN101501194A Protection against and treatment of age related macular degeneration |
| 08/05/2009 | CN101500563A Cycloalkanopyrolocarbazole derivatives and the use thereof as PARP, VEGFR2 and MLK3 inhibitors |
| 08/05/2009 | CN100523187C Modified chimeric polyeptides with improved pharmacokinetic properties |
| 08/05/2009 | CN100522967C Phosphorus-containing compounds & uses thereof |
| 08/05/2009 | CN100522943C Vitamin d analogues |
| 08/05/2009 | CN100522225C Preparation of compound mixture and its inspection |
| 08/05/2009 | CN100522182C Vitamin microelement mineral calcium nutritire product for preventing and treating nightblindness and its manufacturing method |
| 08/05/2009 | CN100522164C Method of treating of demyelinating diseases or conditions |
| 08/05/2009 | CN100522162C New pranoprofen eye drops and its preparation method |
| 08/05/2009 | CN100522150C Angiogenesis inhibitor |
| 08/05/2009 | CN100522149C Novel application of peptide class of compound for treating allodynia or other different types of chronic or phantom pain |
| 08/05/2009 | CN100522147C Application of 5, 6, 7-tri-hydroxy enanthic acid and analog thereof for treating dry eye disorders and uveitis |
| 08/04/2009 | US7569585 Drugs; analgesics; anesthetics; antiarrhythmia agents; antiinflammatory agents ; incontinence; gastrointestinal disorders; neurodegenerative disease |
| 08/04/2009 | CA2433785C Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/04/2009 | CA2406057C Methods and compositions for modulating alpha adrenergic receptor activity |
| 08/04/2009 | CA2392367C Composition and method for treatment of otitis media |
| 08/04/2009 | CA2365281C Human antibodies that bind human il-12 and methods for producing |
| 08/04/2009 | CA2357014C Method of using (2-imidazolin-2-ylamino) quinoxalines in treating neural injury |
| 08/04/2009 | CA2221110C Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents for the treatment of ocular hypertension |
| 08/04/2009 | CA2207850C Use of mono and bicarboxylic acid amides for the manufacture of a medicament active at the peripheral cannabinoid receptor |
| 07/30/2009 | WO2009094466A2 Contact lenses for extended release of bioactive agents containing diffusion attenuators |
| 07/30/2009 | WO2009094286A1 Hydrazines in glaucoma therapy |
| 07/30/2009 | WO2009093970A1 Method of improving wound healing |
| 07/30/2009 | WO2009093049A1 Fused pyridines active as inhibitors of c-met |
| 07/30/2009 | WO2008127975A3 Use of an inhibitor of tnfa plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis |
| 07/30/2009 | WO2007096745A8 Methods for the treatment of macular degeneration and related eye conditions |
| 07/30/2009 | US20090192212 Dithiol Compounds, Derivatives, and Uses Therefor |
| 07/30/2009 | US20090192177 2-ARYL pyrrologpyrimidines for A1 and A3 receptors |
| 07/30/2009 | US20090192109 Compositions for diagnosis and therapy of diseases associated with aberrant expression of Kremen and/or Wnt |
| 07/30/2009 | US20090192105 RNA INTERFERENCE MEDIATED INHIBITION OF INTERCELLULAR ADHESION MOLECULE (ICAM) GENE EXPRESSION USING SHORT INTERFERING NUCELIC ACID (siNA) |
| 07/30/2009 | US20090192089 treatment of cell damage caused by ischemia or stroke by administering to a cell or a tissue an effective amount of an isozyme specific delta PKC (protein kinase C) antagonist |
| 07/30/2009 | US20090192088 Vascular Endothelial Growth Factor 2 |
| 07/30/2009 | US20090191572 Imaging, diagnosis and treatment of disease |